4 July 2016

The Office of Drug Control (ODC), part of the Health Products Regulation Group of the Department of Health, is responsible for:

  • regulating domestic manufacture of narcotic drugs
  • providing in-depth advice regarding travelling with controlled drugs
  • the Commonwealth regulation of medicinal cannabis cultivation, production and manufacture in Australia
  • reporting on activities covered by the Single Convention to the International Narcotic Control Board (INCB)
  • applying amendments to international drug controls in Australia
  • enabling Australians to gain access to essential medications

More information on the work of the office will be added to this new website in the coming months.

About the Office of Drug Control

The Office of Drug Control (ODC) was established on 15 February 2016 to regulate and provide advice on the import, export and manufacture of controlled drugs as well as guidance for travellers who are entering or leaving Australia. The office is responsible for administering the Narcotic Drugs Act 1967 and parts of the Customs (Prohibited Imports) Regulations 1956 and Customs (Prohibited Exports) Regulations 1958 relating to drugs.

Legislation to enable the domestic cultivation and manufacture of cannabis for medicinal and related research purposes was passed by Parliament on 29 February 2016 and will come into effect on or by 30 October 2016. The ODC is currently drafting necessary regulations.